Drug Trial Radar · NCT02812121
UC-MSC Infusion for HBV-Related Acute-on-Chronic Liver Failure
Last checked: Nov 19, 2026Latest source record: Jun 24, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
261
Planned (sponsor's estimate)
Start
Jun 2016
Primary completion
Jun 2017
Study completion Jun 2018
Sponsor
- Lead sponsor
- Sun Yat-sen UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 24, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) is a severe disease with high mortality. Our previous study have demonstrated that peripheral infusion of bone marrow-derived mesenchymal stromal cells (MSCs) weekly for 4 times is safe and improves 24 weeks survival rate of ACLF patients. In this study, we intend to assess the safety and efficacy of umbilical cord blood derived MSCs for HBV-related ACLF patients.
Conditions
- Liver Failure
Interventions
umbilical cord blood mesenchymal stem cellsDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- The incidence of adverse reactions after umbilical cord blood derived mesenchymal stem cells (UC-MSC) infusions.Time frame: 52 weeks
- The survival time of patients after UC-MSC infusions.Time frame: 52 weeks
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.